Company Filing History:
Years Active: 2018-2024
Title: Gionata Frasca: Innovator in Pharmaceutical Chemistry
Introduction
Gionata Frasca is a notable inventor based in Minusio, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of NK-1 antagonists. With a total of 5 patents to his name, Frasca's work has the potential to impact the treatment of various disorders.
Latest Patents
Frasca's latest patents include innovative crystalline forms of an NK-1 antagonist. The invention relates to crystalline forms of 2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethyl-N-(6-(4-methylpiperazin-1-yl)-4-(o-tolyl)pyridin-3-yl)propanamide. This compound is particularly useful in the treatment of induced vomiting and other related disorders. His work in this area demonstrates a commitment to advancing therapeutic options for patients.
Career Highlights
Throughout his career, Gionata Frasca has worked with prominent companies in the pharmaceutical industry. Notable among these are Helsinn Healthcare SA and Taiho Pharmaceutical Company Limited. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in drug development.
Collaborations
Frasca has collaborated with esteemed colleagues, including Christian Bacilieri and Tiziano Fumagalli. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Gionata Frasca's contributions to pharmaceutical chemistry, particularly through his patents on NK-1 antagonists, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments, showcasing the importance of innovation in the field.